Price
Frequently asked questions
What is Intuitive's market capitalization?
What is Intuitive's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Intuitive?
What are the analyst ratings and target price for Intuitive's stock?
What is Intuitive's revenue over the trailing twelve months?
What is the EBITDA for Intuitive?
What is the free cash flow of Intuitive?
What is the 5-year beta of Intuitive's stock?
How many employees does Intuitive have, and what sector and industry does it belong to?
What is the free float of Intuitive's shares?
Financials
Market Cap
$182.99B5Y beta
1.39EPS (TTM)
$6.221Free Float
354.25MP/E ratio (TTM)
82.59Revenue (TTM)
$7.87BEBITDA (TTM)
$2.57BFree Cashflow (TTM)
$586.00MPricing
Analyst Ratings
The price target is $430.04 and the stock is covered by 29 analysts.
Buy
20
Hold
9
Sell
0
Information
Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.
13,676
Medical Equipment & Supplies
Health Care
Identifier
ISIN
Primary Ticker